改变尺寸选择方案对磁性括约肌增强术结局的影响
本研究比较磁性括约肌增强术(MSA)中采用弹出点加2珠(POP+2)与加3珠(POP+3)两种尺寸选择方案患者的术后结局。388例采用POP+2、216例采用POP+3,平均随访14.2个月,两种方案在持续性吞咽困难、pH正常化及扩张或移除需求上无显著差异;但蠕动差或高收缩食管患者从增大尺寸中获益。
要点
- POP+2与POP+3两种尺寸选择方案在持续性吞咽困难、pH正常化及扩张或移除需求上无显著差异。
- 蠕动低于80%或远端收缩积分>5000的患者,增大尺寸可降低吞咽困难发生率。
- 装置尺寸增大与男性比例、BMI>30、术前食管裂孔疝>3 cm、洛杉矶C/D级食管炎及DeMeester评分逐步增加相关。
核心结论
- 从POP+2增至POP+3不减少吞咽困难,也不影响其他MSA结局;但蠕动差或高收缩食管患者可获益。
- 不论尺寸选择方案,术前临床特征随装置尺寸变化,提示尺寸不是可改变因素,而是食管周径的替代指标。
研究设计与样本
- 回顾性比较研究,纳入接受MSA并植入弹出点以上2或3个珠的患者,比较POP+2与POP+3方案的临床与客观结局(术后>1年)。
- POP+2组388例,POP+3组216例;平均随访14.2(7.9)个月。
主要发现
- 总体pH正常化率为73.6%,34.1%需要扩张,15.9%发生持续性吞咽困难,4.0%需要移除装置。
- 尺寸选择方案对持续性吞咽困难(P=0.908)、pH正常化(P=0.822)、扩张需求(P=0.210)或移除需求(P=0.191)均无影响。
- 蠕动<80%的患者中,增大尺寸组吞咽困难发生率为10.3%,未增大组为31%(P=0.048)。
- 远端收缩积分>5000的患者中,增大尺寸组吞咽困难发生率为0%,未增大组为30.4%(P=0.034)。
- 不论尺寸选择方案,装置尺寸增大与男性比例(P<0.0001)、BMI>30(P<0.0001)、术前食管裂孔疝>3 cm(P<0.0001)、洛杉矶C/D级食管炎(P<0.0001)及DeMeester评分(P<0.0001)逐步增加相关;尺寸增大与pH正常化降低(P<0.0001)及扩张需求(P=0.043)或移除需求(P=0.014)相关。
临床怎么用
- 作者认为,从POP+2增至POP+3不减少吞咽困难或影响其他MSA结局,但蠕动差或高收缩食管患者可获益。
- 作者认为,装置尺寸不是可改变因素,而是食管周径的替代指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate and compare magnetic sphincter augmentation (MSA) device sizing protocols on postoperative outcomes and dysphagia. BACKGROUND: Among predictors of dysphagia after MSA, device size is the only factor that may be modified. Many centers have adopted protocols to increase device size. However, there are limited data on the impact of MSA device upsizing protocols on surgical outcomes. METHODS: Patients who underwent MSA were implanted with 2 or 3 beads above the sizing device's pop-off point (POP). Clinical and objective outcomes >1 year after surgery were compared between patients implanted with POP+2-versus-POP+3 sizing protocols. Multiple subgroups were analyzed for the benefit of upsizing. Preoperative and postoperative characteristics were compared between the size patients received, regardless of protocol. RESULTS: A total of 388 patients were implanted under POP+2 and 216 under POP+3. At a mean of 14.2 (7.9) months, pH normalization was 73.6% and 34.1% required dilation, 15.9% developed persistent dysphagia, and 4.0% required removal. The sizing protocol had no impact on persistent dysphagia ( P =0.908), pH normalization ( P =0.822), or need for dilation ( P =0.210) or removal ( P =0.191). Subgroup analysis found that upsizing reduced dysphagia in patients with <80% peristalsis (10.3% vs 31%, P =0.048) or distal contractile integral >5000 (0% vs 30.4%, P =0.034). Regardless of sizing protocol, as device size increased there was a stepwise increase in the percent male sex ( P <0.0001), body mass index >30 ( P <0.0001), and preoperative hiatal hernia >3 cm ( P <0.0001), Los Angeles grade C/D esophagitis ( P <0.0001), and DeMeester score ( P <0.0001). Increased size was associated with decreased pH normalization ( P <0.0001) and need for dilation ( P =0.043) or removal ( P =0.014). CONCLUSIONS: Upsizing from POP+2 to POP+3 does not reduce dysphagia or affect other MSA outcomes; however, patients with poor peristalsis or hypercontractile esophagus do benefit. Regardless of sizing protocol, preoperative clinical characteristics varied among device sizes, suggesting size is not a modifiable factor, but a surrogate for esophageal circumference.
引用
- Sarici IS, Eriksson SE, Zheng P, et al. Impact of Change in Sizing Protocol on Outcome of Magnetic Sphincter Augmentation. Ann Surg. 2024. PMID: 38390758. doi:10.1097/SLA.0000000000006249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。